Voglibose 0.3 mg + Metformin SR 500 mg: Uses & Benefits

Nov 16, 2026

Product Description

Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg Tablets are combination antidiabetic medicines prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus. This combination contains two active ingredients that work through different mechanisms to support better blood sugar control, particularly when diet, exercise, and single-drug therapy do not provide adequate glycemic control.

Voglibose 0.3 mg belongs to the alpha-glucosidase inhibitor class of antidiabetic medicines. It works in the small intestine by slowing the breakdown of carbohydrates into simple sugars. This delays glucose absorption after meals and helps control postprandial hyperglycemia, which refers to an increase in blood sugar levels after eating.

Metformin Hydrochloride 500 mg in sustained-release (SR) form belongs to the biguanide class of antidiabetic medicines. It helps reduce glucose production in the liver, decreases intestinal glucose absorption, and improves the body's sensitivity to insulin. Its sustained-release formulation allows the medicine to release gradually over time.

Together, Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg tablets target different aspects of blood glucose regulation. Voglibose primarily helps control post-meal glucose spikes, while Metformin supports overall blood glucose management by improving insulin sensitivity and reducing excess glucose production.

What Are Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg Tablets Used For?

This combination is primarily prescribed for the management of type 2 diabetes mellitus in adults when lifestyle modifications and treatment with a single antidiabetic medicine are insufficient to achieve appropriate blood glucose control.

The major therapeutic uses include:

  • Management of type 2 diabetes mellitus.
  • Helping reduce elevated blood sugar levels after meals.
  • Supporting overall blood glucose regulation.
  • Improving postprandial glycemic control.
  • Supporting combination treatment when one antidiabetic medicine does not provide sufficient control.
  • Helping patients achieve individualized blood glucose targets as part of a comprehensive diabetes management plan.

How Do Voglibose and Metformin Work?

The two active ingredients work through complementary mechanisms.

1. Voglibose 0.3 mg – Controls Post-Meal Blood Sugar

Voglibose inhibits alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down complex carbohydrates into absorbable sugars.

By slowing carbohydrate digestion, Voglibose delays glucose absorption into the bloodstream. This helps reduce sudden increases in blood glucose after meals.

2. Metformin Hydrochloride (SR) 500 mg – Supports Overall Blood Sugar Control

Metformin works through several mechanisms:

  • Reduces glucose production in the liver.
  • Improves insulin sensitivity in body tissues.
  • Increases peripheral glucose uptake and utilization.
  • Reduces intestinal glucose absorption.

The sustained-release formulation gradually releases Metformin, helping provide prolonged drug delivery.

Key Benefits of Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg Tablets

The combination offers several potential benefits for adults managing type 2 diabetes under medical supervision.

1. Helps Control Postprandial Hyperglycemia

Voglibose slows carbohydrate digestion and glucose absorption, helping reduce blood sugar spikes after meals.

2. Supports Overall Blood Glucose Management

Metformin helps reduce excessive glucose production in the liver and improves insulin sensitivity, supporting better glucose regulation.

3. Dual Mechanism of Action

The combination targets two different pathways involved in blood sugar regulation, providing complementary antidiabetic activity.

4. Sustained-Release Metformin Formulation

The SR formulation gradually releases Metformin, allowing extended drug delivery according to the formulation's design.

5. Supports Combination Diabetes Therapy

Doctors may prescribe this combination when diet, exercise, and treatment with a single antidiabetic medicine are not sufficient to achieve the desired glucose targets.

6. Helps Improve Diabetes Treatment Management

By combining two active ingredients in one tablet, the formulation can simplify a prescribed combination treatment regimen.

Dosage and How to Take Voglibose 0.3 mg and Metformin SR 500 mg Tablets

The dosage depends on the patient's blood glucose levels, kidney function, treatment response, tolerance, and existing medications.

Voglibose-containing combinations are generally administered immediately before meals, while Metformin SR formulations are commonly taken with food. Follow the specific product's prescribing instructions because administration recommendations may vary by formulation.

Important instructions:

  • Take the medicine exactly as prescribed by your doctor.
  • Swallow sustained-release tablets whole unless the product's official instructions specifically state otherwise.
  • Do not crush, chew, or break the tablet unless permitted by the manufacturer.
  • Maintain regular meal timings and a balanced diet.
  • Monitor blood glucose levels as recommended.
  • Do not change the dose or stop treatment without medical advice.

Possible Side Effects

Like other antidiabetic medicines, this combination may cause side effects. The most commonly reported reactions are related to the digestive system.

Common side effects include:

  • Diarrhea or loose stools.
  • Nausea and vomiting.
  • Abdominal discomfort or stomach pain.
  • Flatulence (excessive gas).
  • Abdominal bloating.
  • Loss of appetite.
  • Constipation.
  • Indigestion or heartburn.
  • Changes in taste.

These symptoms may occur because Voglibose affects carbohydrate digestion and Metformin influences gastrointestinal and metabolic processes.

Potentially serious side effects

1. Hypoglycemia (Low Blood Sugar)

Low blood glucose may occur, particularly when this combination is used with insulin or sulfonylurea medicines. Symptoms may include sweating, shaking, dizziness, hunger, confusion, and weakness.

2. Vitamin B12 Deficiency

Long-term Metformin treatment may reduce vitamin B12 absorption in some patients. Doctors may recommend monitoring when clinically appropriate.

3. Lactic Acidosis

Metformin can rarely cause a serious condition called lactic acidosis, particularly in patients with significant kidney impairment or other risk factors. Warning symptoms may include unusual muscle pain, severe weakness, breathing difficulty, unusual sleepiness, and abdominal discomfort. Seek emergency medical attention if these occur.

4. Liver-Related Problems

Serious liver dysfunction and jaundice have been reported with Voglibose-containing treatments. Contact your doctor if you develop yellowing of the skin or eyes or other concerning symptoms.

Precautions and Safety Information

Before starting Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg tablets, inform your doctor about your medical history and current medicines.

  • Kidney disease: Metformin can accumulate when kidney function is significantly impaired. Kidney function must be assessed before and during treatment.
  • Liver disease: Patients with hepatic impairment require careful evaluation. This combination may be unsuitable in hepatic insufficiency.
  • Alcohol consumption: Excessive alcohol intake can increase the risk of metformin-associated lactic acidosis.
  • Gastrointestinal disorders: People with intestinal obstruction, ileus, or certain serious digestive disorders may not be suitable candidates.
  • Pregnancy and breastfeeding: Consult a healthcare professional before using this combination.
  • Surgery and contrast imaging: Metformin may need to be temporarily withheld around certain surgical procedures or iodinated contrast investigations, depending on kidney function and clinical circumstances.
  • Other diabetes medicines: Combining this medicine with insulin or sulfonylureas may increase the risk of hypoglycemia.

Who Can Take This Combination?

Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg tablets may be prescribed to adults with type 2 diabetes who require additional blood glucose control, especially when post-meal glucose levels remain elevated despite existing treatment.

This combination is not suitable for everyone. It is generally contraindicated in certain conditions, including severe renal impairment, diabetic ketoacidosis, metabolic acidosis, and known hypersensitivity to either active ingredient. The exact suitability must be determined by a qualified healthcare professional.

Conclusion

Voglibose 0.3 mg and Metformin Hydrochloride (SR) 500 mg Tablets are a combination antidiabetic formulation designed to support blood sugar management in adults with type 2 diabetes mellitus. The two ingredients provide complementary mechanisms of action: Voglibose helps control post-meal blood glucose spikes by slowing carbohydrate digestion, while sustained-release Metformin reduces hepatic glucose production and improves insulin sensitivity.

This dual-action combination may be useful when diet, exercise, and single-agent antidiabetic therapy do not provide adequate glycemic control. Its potential benefits include improved postprandial glucose regulation, support for overall blood sugar management, and convenient combination treatment.

For optimal treatment outcomes, patients should follow their prescribed dosage, maintain a balanced diet, exercise regularly, and undergo routine blood glucose and kidney function monitoring. Always consult a doctor before starting, changing, or discontinuing this medicine.

Medical Disclaimer: This product information is intended for educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. This is a prescription antidiabetic medicine and should be used only under the supervision of a qualified healthcare professional.

FAQs 

1. What is Voglibose 0.3 mg and Metformin Hydrochloride SR 500 mg used for?

Voglibose 0.3 mg and Metformin Hydrochloride SR 500 mg tablets are used to manage blood sugar levels in adults with type 2 diabetes mellitus. Voglibose helps control post-meal blood glucose spikes, while Metformin reduces glucose production in the liver and improves insulin sensitivity.

2. What are the benefits of Voglibose 0.3 mg and Metformin SR 500 mg tablets?

The main benefits include improved post-meal blood sugar control, support for overall glucose regulation, reduced hepatic glucose production, improved insulin sensitivity, and complementary action through two different antidiabetic mechanisms.

3. How does Voglibose 0.3 mg and Metformin SR 500 mg work?

Voglibose slows carbohydrate digestion and glucose absorption in the small intestine. Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they help manage both post-meal and overall blood glucose levels.

4. When should I take Voglibose 0.3 mg and Metformin SR 500 mg tablets?

Voglibose is generally taken immediately before meals. Metformin SR is commonly taken with food. Follow the specific combination product's prescribing instructions and your doctor's advice regarding exact administration timing.

5. What are the side effects of Voglibose 0.3 mg and Metformin SR 500 mg?

Common side effects include diarrhea, nausea, vomiting, stomach pain, gas, abdominal bloating, constipation, loss of appetite, and taste changes. Rare but serious risks include lactic acidosis and liver-related complications. Consult a doctor if symptoms persist or become severe.

6. Can Voglibose 0.3 mg and Metformin SR 500 mg control post-meal blood sugar?

Yes. Voglibose helps reduce post-meal blood glucose increases by slowing carbohydrate digestion and glucose absorption. Metformin provides additional support by reducing glucose production in the liver and improving insulin sensitivity.

7. Is Voglibose 0.3 mg with Metformin SR 500 mg suitable for type 2 diabetes?

It may be prescribed for adults with type 2 diabetes when lifestyle changes and single-agent treatment do not provide adequate blood glucose control. A doctor must determine whether this combination is appropriate.

8. Can Voglibose and Metformin be taken together?

Yes. Voglibose and Metformin are sometimes prescribed together because they work through different mechanisms. This combination can provide complementary blood glucose control when clinically appropriate.

9. Does Voglibose 0.3 mg and Metformin SR 500 mg cause low blood sugar?

The combination generally has a lower risk of hypoglycemia when used alone than treatments that directly stimulate insulin secretion. However, low blood sugar can occur, especially when combined with insulin or sulfonylureas.

10. Is Metformin SR 500 mg different from regular Metformin 500 mg?

Yes. Metformin SR is a sustained-release formulation designed to release the medicine gradually. Regular immediate-release Metformin releases the medicine more quickly. Their dosing schedules and administration instructions may differ.

11. Can I take Voglibose and Metformin SR 500 mg every day?

This combination may be prescribed for regular daily use as part of a diabetes treatment plan. The frequency and duration depend on the prescribed formulation, kidney function, blood glucose levels, and individual treatment requirements.

12. Who should avoid Voglibose 0.3 mg and Metformin SR 500 mg tablets?

People with severe kidney impairment, metabolic acidosis, diabetic ketoacidosis, certain serious gastrointestinal conditions, or known allergies to the ingredients may need to avoid this combination. Patients with liver disease also require careful evaluation. Consult a doctor before use.

SHARE WITH